More on BMRN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+600.0% Growth)
- Ratings (6.8 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/28/22 *Est.)
- M&A (N/A)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

BioMarin Pharma (NQ:BMRN)
Delayed: 86.85 +2.30 (2.72%)
Prev. Close $84.55  
Open$85.57 
52 Wk High$108.96 
52 Wk Low$62.12 
Day High$86.98 
Day Low$81.75 
P/E N/A  
EPS$-1.27 
Volume2,260,207 

Friends, Peers and Foes (?): AGL, ZTS, ALK, PHR, OSH (more...)

Jun 24, 2022 07:50 AM Stifel Reiterates Buy Rating on BioMarin Pharmaceutical (BMRN) Following Positive CHMP Recommendation for valrox
Jun 24, 2022 07:16 AM BioMarin Pharma (BMRN) Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A
Jun 24, 2022 07:15 AM BioMarin Receives Positive CHMP Opinion in Europe for Valoctocogene Roxaparvovec Gene Therapy to Treat Adults with Severe Hemophilia A
Jun 21, 2022 04:03 PM BioMarin Pharma (BMRN) Announces MHLW in Japan Granted Approval for VOXZOGO for Injection for the Treatment of Children with Achondroplasia, Whose Growth Plates are Not Closed
Jun 21, 2022 04:02 PM BioMarin Announces the Ministry of Health, Labor and Welfare (MHLW) in Japan Granted Approval for VOXZOGO® (vosoritide) for Injection for the Treatment of Children with Achondroplasia, Whose Growth P
Jun 13, 2022 12:32 PM BioMarin Pharma (BMRN) Announces Favorable Results from Global Phase 2 Study of VOXZOGO™ (vosoritide) for Injection in Infants and Young Children with Achondroplasia at ENDO
Jun 13, 2022 12:31 PM BioMarin Announces Favorable Results from Global Phase 2 Study of VOXZOGO™ (vosoritide) for Injection in Infants and Young Children with Achondroplasia at The Endocrine Society Annual Meeting, ENDO
Jun 13, 2022 06:59 AM Wedbush Assumes BioMarin Pharmaceutical Inc. (BMRN) at Neutral
Jun 7, 2022 02:46 PM Form 4 BIOMARIN PHARMACEUTICAL For: Jun 03 Filed by: Ajer Jeffrey Robert
Jun 6, 2022 06:05 AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $106 at Credit Suisse
View All Articles